Last checked at 
(Alliance News) - Faron Pharmaceuticals Oy announced the appointment of Marie-Louise Fjallskog as new chief medical officer on Tuesday.
Fjallskog will join the Finland-based clinical-stage biopharmaceutical company, bringing 30 years of experience in clinical oncology, translational research and drug development.
She was previously chief medical officer at Nasdaq-listed Sensei Biotherapeutics Inc, where she played a key role in the company's USD150 million IPO in the first quarter of 2021.
Faron's chief executive officer, Markku Jalkanen, said: "I am delighted to welcome Marie-Louise to Faron as our Chief Medical Officer during what is a critical time for the Company as we accelerate the execution of our ambitious clinical development programs, including our lead oncology asset bexmarilimab."
The pharmaceutical company's share price rose by 8.4% to 290.00 pence on Tuesday afternoon in London.
By Elizabeth Winter; elizabethwinter@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
